Ioan Andrei Veresiu

Ioan Andrei Veresiu

Auto-generated profile, based on publicly available information

Ioan Andrei Veresiu

Clinical Centre of Diabetes

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2018 in The Analyst
Verified
Journal Article
Closed access
PDF file
ASAndrei Stefancu
Andrei Stefancu
VMVlad Moisoiu
Vlad Moisoiu
CBCorina Bocsa
Corina Bocsa
ZBZoltán Bálint
Zoltán Bálint
DCDaniel-Tudor Cosma
Daniel-Tudor Cosma
FEFlorin Ioan Elec
Florin Ioan Elec
The lack of an accurate point-of-care detection system for microalbuminuria represents an important unmet medical need that contributes to the morbidity and mortality of patients with kidney diseases. In this proof-of-concept study, we used SERS spectroscopy to detect urinary albumin concentrations in the normal-to-mildly increased albuminuria range, a strategy that could be useful for the early diagnosis of renal impairment due to uncontrolled hypertension, cardiovascular disease or diabetes. We analyzed 27 urine samples by SERS, using iodide-modified silver nanoparticles and we could discriminate between groups with high and low albumin concentrations with an overall accuracy of 89%, 93% and 89%, using principal component analysis–linear discriminant analysis and cut-off values of 3, 6 and 10 μg mL−1 for urinary albumin concentrations, respectively. We achieved a detection limit of 3 μg mL−1 for human serum albumin based on the 1002 cm−1 SERS band, attributed to the ring breathing vibration of phenylalanine. Our detection limit is similar to that of the immunoturbidimetric assays and around one order of magnitude below the detection limit of urinary dipsticks used to detect microalbuminuria. We used principal least squares regression for building a spectral model for quantifying albumin. Using an independent prediction set, the R2 and root mean squared error of prediction between predicted and reference values of human serum albumin concentrations were 0.982 and 2.82, respectively. Here, we show that direct SERS spectroscopy has the sensitivity required for detecting clinically relevant concentrations of urinary albumin, a strategy that could be used in the future for the point-of-care screening of microalbuminuria.

22 July 2015 in Medicine and Pharmacy Reports
Verified
Journal Article
Open access
PDF file
Dana Mihaela CiobanuDana Mihaela Ciobanu
Dana Mihaela Ciobanu
HKHélène Kilfiger
Hélène Kilfiger
BABogdan Apan
Bogdan Apan
GRGabriela Roman
Gabriela Roman
IVIoan Andrei Veresiu
Ioan Andrei Veresiu
Background and aims. Resistant hypertension is defined as failure to achieve blood pressure lower than 140/90 mmHg when using three antihypertensive agents or controlled blood pressure with four or more drugs. We aimed at assessing the prevalence of resistant hypertension and to describe a type 2 diabetes population with resistant hypertension.Methods. The retrospective observational study included (n=73) type 2 diabetes subjects with resistant hypertension selected from (n=728) subjects admitted to the Centre of Diabetes, Cluj, Romania. Results. The subjects (70% women) had a mean age of 65.0±8.9 yrs. and diabetes duration 11(6-19) yrs. Prevalence of resistant hypertension was 10%. Chronic diabetes complications and cardiovascular disease were present in 77% and 56% of subjects respectively. On admission, antihypertensive drugs used were: angiotensin-converting enzyme inhibitors or angiotensin II receptors blockers 93%, β-blockers 88%, diuretics 78%, calcium channels blockers 59%, adrenergic α-antagonists 11%. Systolic and diastolic blood pressure were lower in the last compared to first admission day. Diuretics and calcium channels blockers were the most frequently newly added antihypertensive agents.Conclusion. Although the prevalence of resistant hypertension in type 2 diabetes did not differ from the general population, we observed that these patients had increased frequency of chronic diabetic complications. Angiotensin-converting enzyme inhibitors or angiotensin II receptors and β-blockers were the most used antihypertensive drugs, while the most frequently newly prescribed drugs were diuretics and calcium channel blockers.

13 August 2018 in Diabetes Care
Verified
Journal Article
Open access
PDF file
AJAnca Jivănescu
Anca Jivănescu
CBCosmina Ioana Bondor
Cosmina Ioana Bondor
RPRodica Pop-Busui
Rodica Pop-Busui
IVIoan A. Veresiu
Ioan A. Veresiu
DSDiana Sima
Diana Sima
NGNorina A. Gavan
Norina A. Gavan